Correlation Between Chevron Corp and Supernus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Supernus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Supernus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chevron Corp and Supernus Pharmaceuticals, you can compare the effects of market volatilities on Chevron Corp and Supernus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Supernus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Supernus Pharmaceuticals.

Diversification Opportunities for Chevron Corp and Supernus Pharmaceuticals

-0.4

Correlation Coefficient

Chevron Corp  Supernus Pharmaceuticals

Very good diversification

The 3 months correlation between Chevron and Supernus is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Supernus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supernus Pharmaceuticals and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Supernus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supernus Pharmaceuticals has no effect on the direction of Chevron Corp i.e., Chevron Corp and Supernus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Chevron Corp and Supernus Pharmaceuticals

Considering the 90-day investment horizon Chevron Corp is expected to generate 0.5 times more return on investment than Supernus Pharmaceuticals. However, Chevron Corp is 2.02 times less risky than Supernus Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Supernus Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  14,150  in Chevron Corp on December 29, 2024 and sell it today you would earn a total of  2,515  from holding Chevron Corp or generate 17.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Chevron Corp  vs.  Supernus Pharmaceuticals

Chevron Corp

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Chevron Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Chevron Corp showed solid returns over the last few months and may actually be approaching a breakup point.

Supernus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Supernus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Chevron Corp and Supernus Pharmaceuticals

The main advantage of trading using opposite Chevron Corp and Supernus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Supernus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will offset losses from the drop in Supernus Pharmaceuticals' long position.

The idea behind Chevron Corp and Supernus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.